TEVA ANNOUNCES OXYCONTIN LITIGATION DISMISSED; SETTLEMENT WITH PURDUE FINALIZED

Teva Pharmaceutical Industries Ltd. announced today that patent infringement litigation pertaining to Teva's generic version of Purdue's OxyContin (oxycodone HCl extended-release) Tablets has been dismissed by the United States District Court for the Southern District of New York pursuant to a settlement between Teva and The Purdue Frederick Company and certain of its affiliates. Yahoo Finance (http://biz.yahoo.com/bw/061016/20061016005649.html?.v=1)